CanadaBis Capital AI Stock Analysis
Want to see TSE:CANB.H full AI Analyst Report?
CanadaBis Capital (CANB.H) AI Stock Analysis
CanadaBis Capital
(TSXV:CANB.H)
The overall score of 39 reflects significant challenges. Financial performance is poor with declining revenue, negative earnings, and cash burn. The technical trend is strongly bearish, with the stock trading well below its moving averages. Valuation is unattractive due to losses and lack of dividends. While the balance sheet provides some cushion, it is insufficient to offset the operational headwinds.
CanadaBis Capital (CANB.H) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 2.07M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -1.6
- Beta (1Y)
- -0.75
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Canada
- Employees
- 0
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
CanadaBis Capital Business Overview & Revenue Model
Company Description
CanadaBis Capital Inc. is a Canadian firm specializing in the production and distribution of recreational cannabis and its extracted forms. The organization's business activities are divided into three principal divisions: Cultivation and Wholesale,...
CanadaBis Capital Financial Statement Overview
Summary
Revenue has declined for three consecutive years, with TTM revenue down 10.8% YoY. Gross margin contracted to 44.2%, and net loss of $1.29 million in TTM. Balance sheet shows moderate leverage (debt/equity 1.34) but negative ROE. Cash flow negative, raising liquidity concerns. Overall financial health is weak.
Income Statement
25NegativeBalance Sheet
40NegativeCash Flow
20Very Negative| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.90M | 16.90M | 17.95M | 22.22M | 11.67M | 6.87M |
| Gross Profit | 7.33M | 6.98M | 8.82M | 11.78M | 5.57M | 2.52M |
| EBITDA | 800.06K | 800.05K | 2.09M | 5.68M | 1.57M | -1.81M |
| Net Income | -835.20K | -835.20K | 600.28K | 4.44M | 608.33K | -2.68M |
Balance Sheet | ||||||
| Total Assets | 24.54M | 24.54M | 24.55M | 22.96M | 15.48M | 13.28M |
| Cash, Cash Equivalents and Short-Term Investments | 831.06K | 831.06K | 1.68M | 3.23M | 144.88K | 849.50K |
| Total Debt | 7.75M | 7.75M | 6.44M | 7.31M | 7.82M | 8.44M |
| Total Liabilities | 17.83M | 17.83M | 16.45M | 15.62M | 12.84M | 11.46M |
| Stockholders Equity | 6.62M | 6.62M | 8.00M | 7.25M | 2.54M | 1.73M |
Cash Flow | ||||||
| Free Cash Flow | -3.37M | -3.37M | -594.48K | 4.57M | -292.54K | -1.96M |
| Operating Cash Flow | -3.20M | -3.20M | -256.31K | 5.55M | -82.77K | -1.81M |
| Investing Cash Flow | -169.65K | -169.65K | -328.33K | -965.82K | -209.77K | 122.77K |
| Financing Cash Flow | 2.52M | 2.52M | -962.02K | -1.50M | -412.09K | 2.37M |
CanadaBis Capital Peers Comparison
Overall Rating
TSE:CDVA42Neutral
TSE:CANB.H39Underperform
TSE:CVGR37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 42Neutral | CAD 1.10M | -0.73 | 23.24% | ― | -6.27% | 44.49% | |
| 39Underperform | CAD 2.07M | -1.65 | -19.04% | ― | ― | ― | |
| 37Underperform | CAD 1.94M | -1.41 | 64.32% | ― | ― | -26.62% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:CANB.H | CanadaBis Capital, Inc. | 0.01 | -0.03 | -62.50% | |
| TSE:BAMM | Body & Mind | 0.03 | 0.00 | 0.00% | |
| TSE:CVGR | City View Green Holdings, Inc. | 0.03 | -0.06 | -70.59% | |
| TSE:CDVA | CordovaCann Corp | 0.01 | -0.03 | -75.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 04, 2026
